Levosimendan for patients with impaired left ventricular function undergoing cardiac surgery
Department of Cardiothoracic Surgery, Prince of Wales Hospital, Barker Street, Randwick, New South Wales, 2031, Australia *Corresponding author. Tel.: +61-2-9382-0490; fax: +61-2-93820493. E-mail address : tokuda{at}mxb.mesh.ne.jp (Y. Tokuda). The efficacy of levosimendan treatment for a low cardiac...
Saved in:
Published in | Interactive cardiovascular and thoracic surgery Vol. 5; no. 3; pp. 322 - 326 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Eur Assoc Cardio Surg
01.06.2006
|
Online Access | Get full text |
Cover
Loading…
Summary: | Department of Cardiothoracic Surgery, Prince of Wales Hospital, Barker Street, Randwick, New South Wales, 2031, Australia
*Corresponding author. Tel.: +61-2-9382-0490; fax: +61-2-93820493. E-mail address : tokuda{at}mxb.mesh.ne.jp (Y. Tokuda).
The efficacy of levosimendan treatment for a low cardiac output status following cardiac surgery has not been established. Here, we review our initial experiences of the perioperative use of levosimendan. This study is a retrospective uncontrolled trial. Nine patients who underwent cardiac surgery, and developed a low cardiac output status resistant to conventional inotropic support, were given levosimendan. The mean preoperative ejection fraction was 35.2±3.4%. All patients were on concomitant inotropic agents and had previously undergone intra-aortic balloon pumping. Cardiac index increased immediately from 2.14±0.33 l/min/m 2 at baseline to 2.41±0.31 ( P =0.02) at 1 h, rising to 2.67±0.43 ( P <0.001) at 4 h after the loading dose was started. Similarly, the systemic vascular resistance index decreased from 2350±525 dynes/s/cm 5 /m 2 at baseline to 1774±360 ( P =0.002) at 4 h. In the case of all but one of the patients, either the dose of the concomitant inotropic support or the balloon pumping could be weaned down within 24 h after completion of the levosimendan infusion. No withdrawal of levosimendan was required. Levosimendan could constitute a new therapeutic option for postoperative low cardiac output.
Key Words: Levosimendan; Postoperative care; Impaired ventricular function
Related Articles
ICVTS on-line discussion A
Mohamed Fahmy Ibrahim
Interactive CardioVascular and Thoracic Surgery 2006 5: 326.
[Full Text]
[PDF]
ICVTS on-line discussion B
Alexander Wahba
Interactive CardioVascular and Thoracic Surgery 2006 5: 326.
[Full Text]
[PDF] |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1569-9293 1569-9285 |
DOI: | 10.1510/icvts.2005.122390 |